Makula

"Das Gehirn steuert die Gesundheit der Makula. Deswegen therapieren wir mit Hilfe des Gehirns." [1]

Where it wins

• Non-invasive alternative: Offers the "Makula-Netzhaut-Therapie nach J. D. Hancke" (MNTH) as a therapy without surgery, targeting patients seeking alternatives to conventional ophthalmology [1].
• Specialized focus: Positions itself as a "Spezialpraxis" for macular degeneration and retinal diseases, treating wet, dry, and juvenile forms (e.g., Morbus Stargardt) [1].
• Holistic methodology: Combines anamnesis, specific therapy, and success measurement in a 3-step process, leveraging a proprietary anamnesis tool [1].
• International reach: Attracts patients from over 32 countries, indicating a strong reputation and willingness to travel for this specific treatment [1].

Credibility: The clinic's website details the MNTH methodology, lists patient testimonials (e.g., Julika F., Rita W.), and specifies the team composition (Heilpraktiker, Augenoptikermeister) [1].

• Specialized Medical Practice: Operates as a niche medical practice focusing exclusively on macular degeneration and retinal diseases [1].
• Proprietary Therapy Method: Uses the unique "Makula-Netzhaut-Therapie nach J. D. Hancke" (MNTH) as its core service offering [1].
• Service-Based Delivery: Delivers value through direct patient interaction, including diagnosis, therapy, and follow-up care [1].
• Reputation-Driven Growth: Relies on patient testimonials and international referrals to attract clients, rather than broad marketing [1].

• Conventional Ophthalmology: Traditional eye clinics and hospitals that offer surgery and standard medical treatments for macular degeneration [1].
• Other Naturopathic Practices: General naturopathic clinics that may not specialize in eye diseases [1].
• Differentiators: Praxis Hancke differentiates itself through its exclusive focus on macular degeneration, its proprietary MNTH method, and its international reputation [1].
• Threats: Regulatory scrutiny of non-surgical therapies for serious eye conditions and competition from established medical institutions [1].

• Limited Treatment Options: Patients with macular degeneration often face limited or invasive treatment options in conventional medicine [1].
• Fear of Surgery: Many patients seek non-surgical alternatives to avoid the risks and recovery time associated with eye surgery [1].
• Dissatisfaction with Conventional Care: Some patients feel that conventional ophthalmology causes unnecessary fear or offers insufficient holistic care [1].
• Need for Specialized Care: Macular degeneration requires specialized knowledge and treatment, which general practitioners may not provide [1].

Praxis Hancke has carved out a strong niche by offering a non-invasive alternative to surgery for macular degeneration. Its international patient base suggests a significant unmet need. The main risk is regulatory, as MNTH is a specific therapy that may face scrutiny from conventional medical bodies. The opportunity lies in expanding its digital presence to attract more international patients and potentially licensing the MNTH method. The next signal to watch is any regulatory changes regarding naturopathic treatments for retinal diseases.

Expand digital marketing efforts to target international patients more effectively, particularly in regions with high prevalence of macular degeneration. Develop a more robust patient education platform to explain the MNTH method and its benefits compared to conventional treatments. Consider partnerships with international medical tourism agencies to streamline the process for overseas patients. Explore the possibility of publishing clinical outcomes or case studies to build further credibility and attract research interest.